Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals... Show more
Zoetis Inc. (ZTS) maintains a quarterly dividend policy with payments of $0.53 per share, resulting in an annualized total of $2.12. The current yield stands near 2.81%, reflecting a modest but growing income stream. As a dividend growth stock rather than a high-yield name, Zoetis Inc. (ZTS) prioritizes consistent increases alongside business expansion in the animal health sector. The most recent ex-dividend date was July 20, 2026, with the payment scheduled for September 1, 2026.
Zoetis Inc. (ZTS) has built a strong record of dividend growth since initiating payouts. The company has raised its dividend for 15 consecutive years, achieving an average annual increase of roughly 20% over the past 10 years. Quarterly payments have risen steadily, with recent hikes reflecting robust underlying performance. This consistency underscores a long-term strategy focused on returning capital to shareholders while funding innovation and acquisitions.
The dividend appears well-supported by financial metrics. Zoetis Inc. (ZTS) maintains a payout ratio of approximately 33-34%, well below typical thresholds for sustainability. Earnings coverage remains strong, and free cash flow provides additional buffer against economic fluctuations. Low debt levels relative to peers and steady cash generation from core operations further enhance the outlook for ongoing payments without strain on the balance sheet.
Zoetis Inc. (ZTS) delivers a higher yield than the broader healthcare sector average of about 1.58%. Within animal health and pharmaceuticals, the company's combination of yield and growth rate stands out favorably against many competitors that offer lower yields or shorter dividend histories. This profile appeals to investors seeking above-average income with growth potential in a defensive industry.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.
Zoetis Inc. (ZTS) suits dividend growth investors seeking moderate yields with a proven history of annual increases and strong coverage ratios. Long-term investors focused on compounding returns may find the combination of quarterly payments, low payout ratio, and sector stability appealing. Income-oriented investors preferring higher yields might look elsewhere, while conservative portfolios could value the defensive nature of the animal health business. The stock offers a balanced profile for those prioritizing sustainability over immediate high income.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a pet medication company
Industry PharmaceuticalsGeneric